Terlipressin 68225-0257
Product NDC
68225-0257- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- March 2, 2020
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Terlipressin | .85 mg/5mL |
Packaging Options(1)
117 VIAL, SINGLE-DOSE in 1 TRAY (68225-257-00) / 5 mL in 1 VIAL, SINGLE-DOSE